GLP-1 Medically Supervised Weight Optimisation

GLP-1 receptor agonist therapy — commonly known in Germany as the Abnehmspritze — is the primary medically supervised weight loss intervention within Elb-Aesthetic's longevity programme in Dresden, Saxony. GLP-1 agonists mimic the action of the naturally occurring glucagon-like peptide-1 hormone, suppressing appetite, slowing gastric emptying, and improving insulin sensitivity, producing substantial reductions in body weight when combined with lifestyle…

At Elb-Aesthetic, GLP-1 therapy is never prescribed in isolation. The longevity physician conducts an initial comprehensive assessment — including metabolic and laboratory markers — to determine whether the patient is a suitable candidate, what starting dose is appropriate, and how the medication fits into the broader health strategy. This is relevant because GLP-1 agonists interact with other aspects of metabolic health, and the physician needs a full…

The programme is positioned within the clinic's second longevity pillar — Stoffwechsel- und Gewichtsoptimierung (metabolism and weight optimisation) — sitting alongside other vitality interventions. Patients completing the programme at Elb-Aesthetic benefit from continuity of care under a physician who has full visibility of their longevity health profile, including blood work and infusion history. The clinic's Schloßstraße location in Dresden's Altstadt…